FMR LLC Spyre Therapeutics Inc. (SYRE) 13F holding

FMR LLC reported 13,026,187 SYRE shares valued at $1.16B as of 2026-06-30. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.

Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.